Literature DB >> 266397

Chemotherapy of sarcomas of the limbs by regional perfusion.

E T Krementz, R D Carter, C M Sutherland, I Hutton.   

Abstract

From 1957 to 1975, 113 patients with sarcoma of the extremities have been treated with chemotherapy by regional perfusion, either alone or as an adjunct to excisional surgery. Perfusion alone in 54 patients was associated with an early response rate of 83%, but only four patients had complete regression of tumor for longer than three months. When perfusion was followed by immediate or delayed excision, better results were obtained. In 49 Stage I patients and in 24 Stage II patients, cumulative survivals of 66% and 59% were obtained at five years and 66% and 51% at 10 years. The procedure has also been useful in saving functional limbs by converting tumors to operability, and in the palliation of pain and ulceration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266397      PMCID: PMC1396183          DOI: 10.1097/00000658-197705000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Isolated regional perfusion in the treatment of soft tissue sarcomas of the extremities.

Authors:  H Schraffordt Koops; R Eibergen; J Oldhoff; E van der Ploeg; A Vermey
Journal:  Clin Oncol       Date:  1976-09

2.  SYNOVIAL SARCOMA; AN ANALYSIS OF 34 TUMORS.

Authors:  N L CADMAN; E H SOULE; P J KELLY
Journal:  Cancer       Date:  1965-05       Impact factor: 6.860

3.  An experience with sarcomas of the soft tissues in adults.

Authors:  W SHIEBER; P GRAHAM
Journal:  Surgery       Date:  1962-08       Impact factor: 3.982

4.  Hyperbaric oxygenation and mechlorethamine effectiveness.

Authors:  R P LEATHER; C ECKERT
Journal:  Arch Surg       Date:  1963-07

5.  Regional chemotherapy for cancer: experiences with 116 perfusions.

Authors:  J S STEHLIN; R L CLARK; E C WHITE; J L SMITH; A C GRIFFIN; R H JESSE; J E HEALEY
Journal:  Ann Surg       Date:  1960-04       Impact factor: 12.969

6.  The effect of increased oxygen tension on the tumoricidal effect of nitrogen mustard.

Authors:  E T KREMENTZ; L KNUDSON
Journal:  Surgery       Date:  1961-07       Impact factor: 3.982

7.  Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit.

Authors:  O CREECH; E T KREMENTZ; R F RYAN; J N WINBLAD
Journal:  Ann Surg       Date:  1958-10       Impact factor: 12.969

8.  Fibroxanthosarcoma of the soft tissues. A type of malignant fibrous histiocytoma.

Authors:  R L Kempson; M Kyriakos
Journal:  Cancer       Date:  1972-04       Impact factor: 6.860

9.  Selective heat sensitivity of cancer cells. Biochemical and clinical studies.

Authors:  R Cavaliere; E C Ciocatto; B C Giovanella; C Heidelberger; R O Johnson; M Margottini; B Mondovi; G Moricca; A Rossi-Fanelli
Journal:  Cancer       Date:  1967-09       Impact factor: 6.860

10.  Hyperthermic perfusion with chemotherapy for cancers of the extremities.

Authors:  J S Stehlin
Journal:  Surg Gynecol Obstet       Date:  1969-08
View more
  19 in total

Review 1.  [Current state of neoadjuvant therapy of soft tissue sarcoma].

Authors:  M Lehnhardt; T Schmitt; M Bischof; A Daigeler; G Egerer
Journal:  Chirurg       Date:  2011-11       Impact factor: 0.955

2.  Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.

Authors:  D Aderka; P Sorkine; S Abu-Abid; D Lev; A Setton; A P Cope; D Wallach; J Klausner
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

3.  Isolation perfusion of the lower limb with platinum.

Authors:  M Vaglini; F Belli; M Santinami
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

4.  Hyperthermic isolation perfusion of the limbs with cytostatics after surgical excision of sarcomas.

Authors:  F J Lejeune; D Lienard; P Ewalenko
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

5.  Isolation-perfusion of the liver with 5-fluorouracil.

Authors:  W F Sindelar
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

6.  Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

Authors:  A M Eggermont; H Schraffordt Koops; J M Klausner; B B Kroon; P M Schlag; D Liénard; A N van Geel; H J Hoekstra; I Meller; O E Nieweg; C Kettelhack; G Ben-Ari; J C Pector; F J Lejeune
Journal:  Ann Surg       Date:  1996-12       Impact factor: 12.969

7.  Intraperitoneal approach to regional hyperthermia--possible anticancer applications.

Authors:  G V Smith; R MacMillan; J Stribling
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

8.  [Indications for vein interposition in microsurgical reconstruction of complex defects of the lower extremity after tumor and trauma].

Authors:  G Germann; H U Steinau
Journal:  Unfallchirurgie       Date:  1993-12

9.  [Stroma-free hemoglobin solution and perfusion of isolated extremities].

Authors:  P Hild; K Schwemmle; E Zscherpe; F Pfannkuch
Journal:  Langenbecks Arch Chir       Date:  1984

Review 10.  Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.

Authors:  Cornelis Verhoef; Johannes H W de Wilt; Dirk J Grünhagen; Albertus N van Geel; Timo L M ten Hagen; Alexander M M Eggermont
Journal:  Curr Treat Options Oncol       Date:  2007-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.